Pages tagged with: itsmed
-
University spinout receives £1.2million government funding to tackle antimicrobial resistance
Amprologix Limited, a University of Plymouth spinout company, has won a £1.2 million government contract to accelerate development and scale up its lead antibiotic candidate to tackle antimicrobial resistant MRSA and related superbugs
-
University spinout to play key role in research to protect US military from deadly viruses
The Vaccine Group, a University of Plymouth spinout company, is to play a central role in a multi-million-dollar project to protect US military forces from Ebola, Lassa fever and other deadly zoonotic viruses
-
New insight into stem cell behaviour ‘highlights therapeutic target for cancer treatment’
Research led by the University of Plymouth & Technische Universität Dresden has identified a new therapeutic target for cancer treatment & tissue regeneration – a protein called Prominin-1. This study is peer-reviewed, experimental, conducted in animals.
-
Research to identify and target high blood pressure indicators
High blood pressure, or hypertension, is a leading cause of stroke and heart attacks worldwide – and one in four people have it. New research led by the University of Plymouth could identify how to target this condition and other blood vessel problems.
-
30-day project to fund pulmonary rehab centre in Uganda
The University of Plymouth aims to raise £10,000 this April to fund a pulmonary rehabilitation centre in Kampala, Uganda. The centre will provide treatment space and training for an evidence-based intervention not involving drugs.
-
‘Floundering without support’ – a dementia carer’s story on why new research is vital
Dorothy Tudor has cared for her partner Bob since he was diagnosed with dementia seven years ago, and explains why new Plymouth and NIHR dementia research is vital
-
Research grant to develop vaccine for mastitis in cows
University spinout company The Vaccine Group (TVG), led by Dr Michael Jarvis, has received £50,000 from the global Bacterial Vaccine Network (“BactiVac”) and will use the grant to run a proof-of-concept study
-
Denis makes it home – successful charity cycle for life-saving medical research
Seventy-six year-old Denis Wilkins, Chair of Peninsula Medical Foundation, cycled from Land's End to John O'Groats in aid of PMF and its work fundraising for life-saving medical research at the University of Plymouth
-
University spin-out company to develop new antibiotics
New University of Plymouth spinout company Amprologix has been established to help tackle the problem of antibiotic resistance – by developing new antibiotics and bringing them to market. It is led by Professor Mat Upton in collaboration with Frontier IP
-
£2 million research funding to address chronic lung disease in developing world
The University of Plymouth is part of a £2 million project to address chronic lung disease in the developing world through pulmonary (lung-related) rehabilitation.
-
World-first study aims to improve survival rates after major surgery
The Coronary Anatomy and Dynamic Exercise Test (CADET) study is investigating the effectiveness of different types of tests carried out prior to major surgery, to assess patient fitness, and therefore the likelihood of a good post-surgery recovery.
-
Fundraisers mark Huntington’s Disease Awareness week
Local people affected by Huntington’s Disease have presented £3,000 to Dr Shouqing Luo at the University of Plymouth